nmoira

Thanks everyone. 🙂

I've chosen the Ipi/GR-MD-02 trial. They're working on the pre-auths for the Ipi and the scans, so I should be good to go by the end of next week.

Thanks everyone. 🙂

I've chosen the Ipi/GR-MD-02 trial. They're working on the pre-auths for the Ipi and the scans, so I should be good to go by the end of next week.

Thanks everyone. 🙂

I've chosen the Ipi/GR-MD-02 trial. They're working on the pre-auths for the Ipi and the scans, so I should be good to go by the end of next week.

Thanks. The original PET/CT showed nothing in the brain, but of course are not optimal tests. A brain MRI about six weeks ago was clear. If I choose the Ipi and GR-MD-02 trial, I'll have another PET/CT  for a baseline and a brain MRI to determine elibility. If going the Ipi route, I'm inclined to enter this trial as I'd be receiving full doses of Ipi, and the GR-MD-02 looks… interesting.

http://www.clinicaltrials.gov/show/NCT02117362

Thanks. The original PET/CT showed nothing in the brain, but of course are not optimal tests. A brain MRI about six weeks ago was clear. If I choose the Ipi and GR-MD-02 trial, I'll have another PET/CT  for a baseline and a brain MRI to determine elibility. If going the Ipi route, I'm inclined to enter this trial as I'd be receiving full doses of Ipi, and the GR-MD-02 looks… interesting.

http://www.clinicaltrials.gov/show/NCT02117362

Thanks. The original PET/CT showed nothing in the brain, but of course are not optimal tests. A brain MRI about six weeks ago was clear. If I choose the Ipi and GR-MD-02 trial, I'll have another PET/CT  for a baseline and a brain MRI to determine elibility. If going the Ipi route, I'm inclined to enter this trial as I'd be receiving full doses of Ipi, and the GR-MD-02 looks… interesting.

http://www.clinicaltrials.gov/show/NCT02117362

Thanks, that's a good point about the Ipi.

In the original post I meant the imminent approval of the Merck drug, not Nivo. My oncologist thinks its approval could be as early as July… but we're keeping it in mind. 

Thanks, that's a good point about the Ipi.

In the original post I meant the imminent approval of the Merck drug, not Nivo. My oncologist thinks its approval could be as early as July… but we're keeping it in mind. 

Thanks, that's a good point about the Ipi.

In the original post I meant the imminent approval of the Merck drug, not Nivo. My oncologist thinks its approval could be as early as July… but we're keeping it in mind.